Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 12.6
(-0.24%)
CNY 12.6
(-0.24%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 33.98 Million CNY | 112.28% |
| 2022 | -292.04 Million CNY | -458.09% |
| 2021 | 81.55 Million CNY | 81.38% |
| 2020 | 44.96 Million CNY | 109.24% |
| 2019 | -486.85 Million CNY | -1220.7% |
| 2018 | 43.44 Million CNY | -35.28% |
| 2017 | 67.12 Million CNY | 58.71% |
| 2016 | 42.29 Million CNY | -31.42% |
| 2015 | 61.67 Million CNY | 20.69% |
| 2014 | 51.1 Million CNY | 33.06% |
| 2013 | 38.4 Million CNY | 15.77% |
| 2012 | 33.17 Million CNY | -14.83% |
| 2011 | 38.94 Million CNY | 14.85% |
| 2010 | 33.91 Million CNY | 211.35% |
| 2009 | 10.89 Million CNY | 133.46% |
| 2008 | 4.66 Million CNY | 49.66% |
| 2007 | 3.11 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 19.56 Million CNY | 305.99% |
| 2024 Q2 | 5.25 Million CNY | -73.15% |
| 2024 Q3 | 5.44 Million CNY | 3.59% |
| 2023 Q2 | 6.09 Million CNY | -78.04% |
| 2023 FY | 35.86 Million CNY | 112.28% |
| 2023 Q4 | -9.49 Million CNY | -190.42% |
| 2023 Q1 | 27.75 Million CNY | 145.83% |
| 2023 Q3 | 10.5 Million CNY | 72.34% |
| 2022 Q1 | 27.58 Million CNY | 85.28% |
| 2022 Q4 | -60.55 Million CNY | -1097.48% |
| 2022 Q2 | -265.14 Million CNY | -1061.1% |
| 2022 Q3 | 6.07 Million CNY | 102.29% |
| 2022 FY | -292.04 Million CNY | -458.09% |
| 2021 Q4 | 14.88 Million CNY | -25.84% |
| 2021 Q3 | 20.07 Million CNY | -12.54% |
| 2021 Q2 | 22.95 Million CNY | -2.87% |
| 2021 Q1 | 23.63 Million CNY | 660.81% |
| 2021 FY | 81.55 Million CNY | 81.38% |
| 2020 Q3 | 15.42 Million CNY | -20.48% |
| 2020 FY | 44.96 Million CNY | 109.24% |
| 2020 Q4 | -4.21 Million CNY | -127.32% |
| 2020 Q2 | 19.39 Million CNY | 35.16% |
| 2020 Q1 | 14.35 Million CNY | 102.87% |
| 2019 Q3 | 6.75 Million CNY | 250.23% |
| 2019 FY | -486.85 Million CNY | -1220.7% |
| 2019 Q1 | 10.77 Million CNY | -50.84% |
| 2019 Q4 | -499.89 Million CNY | -7498.77% |
| 2019 Q2 | -4.49 Million CNY | -141.74% |
| 2018 Q3 | 21.29 Million CNY | 382.46% |
| 2018 Q4 | 21.91 Million CNY | 2.95% |
| 2018 FY | 43.44 Million CNY | -35.28% |
| 2018 Q2 | -7.53 Million CNY | -196.99% |
| 2018 Q1 | 7.77 Million CNY | -48.36% |
| 2017 FY | 67.12 Million CNY | 58.71% |
| 2017 Q1 | 12.32 Million CNY | -39.33% |
| 2017 Q2 | 11.86 Million CNY | -3.7% |
| 2017 Q3 | 27.89 Million CNY | 135.08% |
| 2017 Q4 | 15.04 Million CNY | -46.05% |
| 2016 Q4 | 20.3 Million CNY | 62.02% |
| 2016 FY | 42.29 Million CNY | -31.42% |
| 2016 Q2 | 2.84 Million CNY | -56.92% |
| 2016 Q1 | 6.6 Million CNY | -79.33% |
| 2016 Q3 | 12.53 Million CNY | 340.47% |
| 2015 Q4 | 31.96 Million CNY | 129.92% |
| 2015 FY | 61.67 Million CNY | 20.69% |
| 2015 Q3 | 13.9 Million CNY | 93.01% |
| 2015 Q2 | 7.2 Million CNY | -16.35% |
| 2015 Q1 | 8.61 Million CNY | -60.6% |
| 2014 Q3 | 12.92 Million CNY | 60.71% |
| 2014 Q4 | 21.85 Million CNY | 69.09% |
| 2014 FY | 51.1 Million CNY | 33.06% |
| 2014 Q1 | 8.28 Million CNY | -46.71% |
| 2014 Q2 | 8.04 Million CNY | -2.89% |
| 2013 Q3 | 8.75 Million CNY | 27.41% |
| 2013 Q2 | 6.86 Million CNY | -5.11% |
| 2013 Q1 | 7.23 Million CNY | 48.9% |
| 2013 FY | 38.4 Million CNY | 15.77% |
| 2013 Q4 | 15.54 Million CNY | 77.56% |
| 2012 Q1 | 15.24 Million CNY | -25.71% |
| 2012 Q2 | 6.73 Million CNY | -55.84% |
| 2012 Q3 | 6.32 Million CNY | -6.05% |
| 2012 Q4 | 4.86 Million CNY | -23.14% |
| 2012 FY | 33.17 Million CNY | -14.83% |
| 2011 FY | 38.94 Million CNY | 14.85% |
| 2011 Q2 | 7.65 Million CNY | 289.7% |
| 2011 Q3 | 8.8 Million CNY | 14.99% |
| 2011 Q4 | 20.52 Million CNY | 133.23% |
| 2011 Q1 | 1.96 Million CNY | -88.79% |
| 2010 FY | 33.91 Million CNY | 211.35% |
| 2010 Q2 | 8.05 Million CNY | 591.75% |
| 2010 Q3 | 9.96 Million CNY | 23.7% |
| 2010 Q4 | 17.52 Million CNY | 75.83% |
| 2010 Q1 | -1.63 Million CNY | 0.0% |
| 2009 FY | 10.89 Million CNY | 133.46% |
| 2008 FY | 4.66 Million CNY | 49.66% |
| 2007 FY | 3.11 Million CNY | 0.0% |